Utilization of Rituximab for Refractory Rowell Syndrome
Rowell syndrome describes the occurrence of erythema multiforme-like lesions in patients with cutaneous lesions of lupus erythematosus. The clinical picture of atypical erythema multiforme-like lesions, presence of chilblains, speckled ANA pattern, anti-Ro/SSA, or anti-La/SSB antibodies, and absence...
Saved in:
Main Authors: | Sukhraj Singh, Sandra Sheffield, Nisha Chowdhury, Swetha Nuthulaganti, Zareen Vaghaiwalla, Karishma Ramsubeik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2021/2727382 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Curious Case of Rowell Syndrome
by: Seetharaman Venugopalan Iyer, et al.
Published: (2025-01-01) -
Rituximab in Refractory Myasthenia Gravis – Challenges and Lessons Learnt
by: Karthika A Valaparambil, et al.
Published: (2024-12-01) -
Remission Achieved in Refractory Advanced Takayasu Arteritis Using Rituximab
by: D. Ernst, et al.
Published: (2012-01-01) -
Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare
by: Emmanuel Ribeiro, et al.
Published: (2009-01-01) -
Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension
by: Yuyu Li, et al.
Published: (2025-01-01)